Literature DB >> 10744778

A locus conferring resistance to diet-induced hypercholesterolemia and atherosclerosis on mouse chromosome 2.

A Mouzeyan1, J Choi, H Allayee, X Wang, J Sinsheimer, J Phan, L W Castellani, K Reue, A J Lusis, R C Davis.   

Abstract

Dietary cholesterol is known to raise total and low density lipoprotein cholesterol concentrations in humans and experimental animals, but the response among individuals varies greatly. Here we describe a mouse strain, C57BL/6ByJ (B6By), that is resistant to diet-induced hypercholesterolemia, in contrast to the phenotype seen in other common strains of mice including the closely related C57BL/6J (B6J) strain. Compared to B6J, B6By mice exhibit somewhat lower basal cholesterol levels on a chow diet, and show a relatively modest increase in absolute levels of total and LDL/VLDL cholesterol in response to an atherogenic diet containing 15% fat, 1.25% cholesterol, and 0.5% cholate. Correspondingly, B6By mice are also resistant to diet-induced aortic lesions, with less than 15% as many lesions as B6J. Food intake and cholesterol absorption are similar between B6By and B6J mice. To investigate the gene(s) underlying the resistant B6By phenotype, we performed genetic crosses with the unrelated mouse strain, A/J. A genome-wide scan revealed a locus, designated Diet1, on chromosome 2 near marker D2Mit117 showing highly significant linkage (lod = 9.6) between B6By alleles and hypo-response to diet. Examination of known genes in this region suggested that this locus represents a novel gene affecting plasma lipids and atherogenesis in response to diet.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10744778

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

Review 1.  Gene-diet interaction and plasma lipid response to dietary intervention.

Authors:  J M Ordovas
Journal:  Curr Atheroscler Rep       Date:  2001-05       Impact factor: 5.113

2.  Diet1 is a regulator of fibroblast growth factor 15/19-dependent bile acid synthesis.

Authors:  Karen Reue; Jessica M Lee; Laurent Vergnes
Journal:  Dig Dis       Date:  2015-05-27       Impact factor: 2.404

Review 3.  Bile acids as metabolic regulators.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Curr Opin Gastroenterol       Date:  2015-03       Impact factor: 3.287

4.  Diet1, bile acid diarrhea, and FGF15/19: mouse model and human genetic variants.

Authors:  Jessica M Lee; Jessica R Ong; Laurent Vergnes; Thomas Q de Aguiar Vallim; Jonathan Nolan; Rita M Cantor; Julian R F Walters; Karen Reue
Journal:  J Lipid Res       Date:  2018-01-02       Impact factor: 5.922

5.  Diet1 functions in the FGF15/19 enterohepatic signaling axis to modulate bile acid and lipid levels.

Authors:  Laurent Vergnes; Jessica M Lee; Robert G Chin; Johan Auwerx; Karen Reue
Journal:  Cell Metab       Date:  2013-06-04       Impact factor: 27.287

6.  Quantitative trait loci for individual adipose depot weights in C57BL/6ByJ x 129P3/J F2 mice.

Authors:  Danielle R Reed; Amanda H McDaniel; Xia Li; Michael G Tordoff; Alexander A Bachmanov
Journal:  Mamm Genome       Date:  2006-11-10       Impact factor: 2.957

7.  Candidate genes for obesity revealed from a C57BL/6J x 129S1/SvImJ intercross.

Authors:  Z Su; R Korstanje; S-W Tsaih; B Paigen
Journal:  Int J Obes (Lond)       Date:  2008-04-15       Impact factor: 5.095

Review 8.  Regulation of bile acid homeostasis by the intestinal Diet1-FGF15/19 axis.

Authors:  Karen Reue; Jessica M Lee; Laurent Vergnes
Journal:  Curr Opin Lipidol       Date:  2014-04       Impact factor: 4.776

9.  Genetic dissection of quantitative trait Loci for hemostasis and thrombosis on mouse chromosomes 11 and 5 using congenic and subcongenic strains.

Authors:  Jane Hoover-Plow; Qila Sa; Menggui Huang; Jessica Grondolsky
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

Review 10.  The Role of FGF19 and MALRD1 in Enterohepatic Bile Acid Signaling.

Authors:  Linda X Wang; Mark R Frey; Rohit Kohli
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-18       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.